Many studies have shown that progressive human kidney disease seriously affects the quality of life of patients and may lead to their death. Here, the authors show that targeting of NRP1 represents a promising strategy for the treatment of kidney injury and subsequent chronic kidney disease.
- Yinzheng Li
- Zheng Wang
- Rui Zeng
